BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2230926
,
CYP51
,
glucose metabolic process
,
Diabetes mellitus
,
Adipose tissue
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
fk506
Summary
General Info
Curated Studies
Most Correlated Studies
Granulocyte-monocyte progenitors treated with cyclosporine A (CsA) or FK506
Macrophages pretreated with calcineurin inhibitor FK506 and infected with Aspergillus fumigatus
Splenic long term dendritic D1 cell line treated with curdlan and immunosuppressant FK506
RNAs associated with Slf1p and Sro9p in yeast
Peripheral blood mononuclear cells treated with TCR activators and calcium signaling inhibitors
Explore Curated Studies Results
Literature
Most Relevant Literature
Fk506 Inhibit Liver Regeneration in HOC Model Rat.
Diversified targets of FKBP25 and its complex with rapamycin.
Production improvement of FK506 in Streptomyces tsukubaensis by metabolic engineering strategy.
Computational insights into the suicide inhibition of Plasmodium falciparum Fk506-binding protein 35…
Optimization of FK-506 production in Streptomyces tsukubaensis by modulation of Crp-mediated regulat…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
FK506 (Tacrolimus) in Pulmonary Arterial Hypertension
To Compare the Efficacy and Safety of FK506 vs IVC in the Treatment of Class III-IV LN
Phase III Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjun…
Phase III, Long-Term, Open-Label, Extension Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in…
Investigation of Pain Incidence After FK506 Immunosuppressive Therapy in Liver Transplantation Patie…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ